Our mission at Semorex is to develop and commercialize innovative technologies based on our proprietary imprinted polymers for

• Detection of toxic proteins (i.e., Ricin).
• Development of novel therapeutics for treatment of major diseases by selective removal of proteins from the GI tract (i.e., Gliadin - for Celiac disease, TNFa - for inflammatory bowel diseases, Ghrelin - for obesity treatment).

We have also developed

• Novel, non-toxic small-molecule therapeutics for cancer.
• Novel diagnosis for systemic fungal infection (lateral flow device, mass spectroscopy).